Tal Zvi Zaks, Chief Medical Officer at Moderna, Inc. (MRNA), sold 30,683 shares at $123.48 ($3.9M) on 2021-03-08, disclosed to the SEC on 2021-03-10.
Open-market sale of $3.9M MRNA by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $123.48 | 1,547 | $191K | 4.8% |
| 2 | $123.48 | 1,547 | $191K | 4.8% |
| 3 | $124.35 | 273 | $34K | 0.9% |
| 4 | $125.68 | 1,361 | $171K | 4.3% |
| 5 | $125.68 | 1,361 | $171K | 4.3% |
| 6 | $126.75 | 1,350 |
| $171K |
| 4.3% |
| 7 | $126.75 | 1,350 | $171K | 4.3% |
| 8 | $127.73 | 1,855 | $237K | 6.0% |
| 9 | $127.73 | 1,855 | $237K | 6.0% |
| 10 | $128.62 | 2,698 | $347K | 8.8% |
| 11 | $128.62 | 2,698 | $347K | 8.8% |
| 12 | $129.80 | 2,312 | $300K | 7.6% |
| 13 | $129.80 | 2,312 | $300K | 7.6% |
| 14 | $130.76 | 2,611 | $341K | 8.7% |
| 15 | $130.76 | 2,611 | $341K | 8.7% |
| 16 | $131.83 | 2,000 | $264K | 6.7% |
| 17 | $132.91 | 471 | $63K | 1.6% |
| 18 | $132.91 | 471 | $63K | 1.6% |
| Total | $128.41 avg | 30,683 | $3.9M | 100% |
| Filing → |
| MRNA | SELL | 2021-06-25 | $1.1M | — | Filing → |
| MRNA | SELL | 2021-06-21 | $1.0M | — | Filing → |
| MRNA | SELL | 2021-06-11 | $1.1M | — | Filing → |